PPARG and neoplasm: Furthermore, significantly higher PPARγ mRNA was observed in primary AML patients.63 Therefore, in addition to revealing the contribution of epigenetic- and PPARγ-mediated inactivation of CEBPD in leukemic cells, the issue of how to efficiently activate CEBPD for executing its tumor suppressor role in leukemia remains an open question.